Search

for
Search:

Did you mean Atypical Antipsychotics?

GlossaryAtypical Antipsychotics

medications treating psychiatric conditions with fewer movement disorder side effects

Atypical Antipsychotics, also known as Second-Generation Antipsychotics (SGAs), are a class of medications used to treat psychiatric conditions such as schizophrenia and bipolar disorder. Unlike first-generation antipsychotics, they are less likely to cause movement disorders like tardive dyskinesia and often have a broader range of action, affecting both dopamine and serotonin receptors in the brain.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

research Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion After Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – An Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications

November 2007 in “Hospital pharmacy”

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

research Polycystic Ovarian Syndrome in Patients with Schizophrenia Treated with Atypical Antipsychotics: A Case Control Study

April 2017 in “European Psychiatry”

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

research Management of the Psychological Comorbidities of Dermatological Conditions: Practitioners' Guidelines

23 citations, April 2017 in “Clinical, Cosmetic and Investigational Dermatology”

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

research Alopecia Associated with Quetiapine

19 citations, February 2007 in “International Clinical Psychopharmacology”

Quetiapine may cause hair loss, a side effect not widely recognized before.

research Olanzapine Induced Hair Loss: A Case Report

9 citations, October 2012 in “Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology”

Stopping the drug olanzapine can reverse hair loss caused by it.

View more "atypical antipsychotic" in research →

Community Join

5 / 77 results

community FINASTRIDE and switch to DUTASTRIDE, my experience

in Progress Pictures 135 upvotes 2 months ago

The user shared their experience with Finasteride and Dutasteride for hair loss. They initially had success with Finasteride but switched to Dutasteride after experiencing shedding, which continued, and are now considering a hair transplant.

community Dutasteride takes 1-3 months to work in the scalp. Not weeks. Be careful.

in Finasteride/Dutasteride 41 upvotes 3 months ago

Dutasteride takes 1-3 months to affect scalp DHT levels, not just a week. The prostate absorbs Dutasteride faster than the scalp due to different vascular networks and enzyme densities.

community I was scared of Fin. I now love it

in Update 19 upvotes 11 months ago

A 25-year-old male switched from multiple topicals to finasteride and minoxidil for hair loss, experiencing maintenance and increased confidence despite minor side effects. He now styles his hair freely and appreciates the positive impact of finasteride.

community Low level chronic allergies and hair loss

in Research/Science 6 upvotes 10 months ago

Hair loss can be influenced by chronic low-level allergies, and treatments like fexofenadine or topical cetirizine may help with regrowth. The user avoids finasteride, dutasteride, and minoxidil, and has tried Regenera Activa and PRF sessions.

community If you’ve had hair loss due to low iron levels, how long did it take for regrowth after beginning supplements?

in Female 7 upvotes 4 years ago

Hair loss due to low iron levels and the potential of regrowth after beginning supplements such as spiro, minoxidil, and finasteride.

View more "atypical antipsychotic" in community →